tradingkey.logo

Bayer rises on US Supreme Court hearing decision

ReutersJan 19, 2026 8:31 AM

Shares of the Bayer BAYGn.DE rise 7% after the U.S. Supreme Court granted a hearing to the German life sciences company

A local trader points to developments in the Roundup weed killer lawsuits Bayer faces

The US Supreme Court agreed to hear Bayer's bid to curb cases claiming that Roundup causes cancer

Bayer expects a decision on merits by June 2026, the trader says

The stock is up 20% year-to-date and is on a 27-month high

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI